Form 4: Hims & Hers Health CMO Patrick Carroll Reports Routine Stock Transactions and RSU Vesting

Hims & Hers Health, Inc.'s Chief Medical Officer and Director, Patrick Harrison Carroll, reported the acquisition of Class A Common Stock through RSU vesting and subsequent share disposal for tax obligations.

Summary

• Patrick Harrison Carroll, Chief Medical Officer and Director of Hims & Hers Health, Inc., reported transactions involving the company's Class A Common Stock and Restricted Stock Units (RSUs).
• On June 12, 2025, Mr. Carroll acquired 9,935 shares of Class A Common Stock through the vesting and exercise of RSUs.
• On June 13, 2025, he acquired an additional 16,521 shares of Class A Common Stock through the vesting and exercise of RSUs.
• Also on June 13, 2025, 6,177 shares of Class A Common Stock were disposed of at a price of $55.48 per share to cover tax withholding obligations related to the RSU vesting.
• Following these transactions, Mr. Carroll's direct beneficial ownership of Class A Common Stock stands at 229,940 shares.
• Several tranches of Restricted Stock Units (RSUs) vested, including 3,533, 4,839, 9,935, and 8,149 units, which converted into Class A Common Stock.
• Remaining beneficially owned derivative securities include 52,996, 53,236, and 48,892 Restricted Stock Units, with 0 RSUs remaining from the 9,935 unit grant that fully vested.

Sentiment

Score: 6

Explanation: The sentiment is neutral to slightly positive. The transactions are routine compensation events (RSU vesting and tax withholding), which are expected. The executive's continued beneficial ownership and the net increase in shares from vesting are mildly positive, indicating ongoing alignment with company performance, but there's no significant new information to drive strong sentiment.

Positives

• The transactions reflect the vesting of executive compensation, indicating the company is fulfilling its obligations to its Chief Medical Officer.
• The net increase in direct beneficial ownership of Class A Common Stock by a key executive (from 219,596 to 229,940 shares after the first transaction and tax withholding) can be viewed as a positive sign of continued alignment with shareholder interests.

Negatives

• The disposal of 6,177 shares to cover tax withholding obligations, while a standard practice for RSU vesting, represents a reduction in the executive's direct shareholding.

Future Outlook

This Form 4 filing primarily details past and current insider transactions related to compensation and does not contain forward-looking statements or guidance regarding the company's future performance or strategic outlook.

Industry Context

This filing is a routine disclosure of insider stock transactions, common across all publicly traded companies, and does not provide specific insights into broader industry trends or competitive dynamics within the telehealth or healthcare sector.

Stakeholder Impact

• Shareholders: Provides transparency into executive compensation and stock ownership, which can influence investor confidence.
• Employees: Reflects standard executive compensation practices, which may be part of broader company compensation strategies.
• Reporting Person (Patrick Harrison Carroll): Directly impacts his personal wealth and equity stake in Hims & Hers Health, Inc.

Next Steps

• Future vesting of remaining Restricted Stock Units will occur on specified Company Quarterly Vesting Dates (March 15, June 15, September 15, December 15) over the next few years, subject to continuous service.

Key Dates

Keywords

Hims & Hers Health, HIMS, Form 4, Insider Transaction, Restricted Stock Units, RSU Vesting, Executive Compensation, Stock Ownership, Patrick Harrison Carroll, Share Disposal, Tax Withholding